Octagon Capital Advisors LP Century Therapeutics, Inc. Transaction History
Octagon Capital Advisors LP
- $639 Million
- Q1 2024
A detailed history of Octagon Capital Advisors LP transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 540,000 shares of IPSC stock, worth $1.38 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
540,000Holding current value
$1.38 Million% of portfolio
0.35%Shares
7 transactions
Others Institutions Holding IPSC
# of Institutions
67Shares Held
19.7MCall Options Held
10.6KPut Options Held
300-
Vr Adviser, LLC New York, NY3.41MShares$8.68 Million1.22% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$8.18 Million1.08% of portfolio
-
Boxer Capital, LLC San Diego, CA1.75MShares$4.46 Million0.38% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$3.82 Million0.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.31MShares$3.33 Million1.32% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $150M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...